IncFact
Company Profiles: Revenue, Growth, Competition

Rx-360 International Pharmaceutical Supply Chain Consortium Revenue, Growth & Competitor Profile

Last updated:

Company Awards

Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Rx-360 International Pharmaceutical Supply Chain Consortium

Access the complete profile.

Rx-360 International Pharmaceutical Supply Chain Consortium Fast Facts

Revenue$1 - $10 million    See Exact Annual Revenue
Employees1 - 10Exact Company Size
Primary Industry339112 Surgical & Medical Instrument Manufacturing
AddressPo Box 40931
Philadelphia, PA 19107

Note: Revenues for privately held companies are statistical evaluations.


Rx-360 International Pharmaceutical Supply Chain Consortium's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
    • Rx-360 International Pharmaceutical Supply Chain Consortium's annual revenues are $1 - $10 million (see exact revenue data)
  • What industry is the company in?
    • Rx-360 International Pharmaceutical Supply Chain Consortium is classified as operating in the Surgical & Medical Instrument Manufacturing industry, NAICS Code 339112.

Rx-360 International Pharmaceutical Supply Chain Consortium Annual Revenue and Growth Rate

Rx-360 International Pharmaceutical Supply Chain Consortium Revenue Est.
($ Million)
Growth Rate (%)# Employees
2023 $1 - $10 million

Details in Premium Report
2022
2021
2020
2019


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Rx-360 International Pharmaceutical Supply Chain Consortium's revenues are gauged from an analysis of company filings.



Rx-360 International Pharmaceutical Supply Chain Consortium's Income Statement (based on Industry Averages)

Rx-360 International Pharmaceutical Supply Chain Consortium P&L$ Millions
Revenue (Sales) Rx-360 International Pharmaceutical Supply Chain Consortium Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications show the products and services that Rx-360 International Pharmaceutical Supply Chain Consortium is developing and marketing. Rx-360 International Pharmaceutical Supply Chain Consortium doesn't have any recent trademark applications, indicating Rx-360 International Pharmaceutical Supply Chain Consortium is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
RX 360 JOINT AUDIT PROGRAM
Organizing and conducting a product safety auditing program of pharmaceutical suppliers and pharmaceutical ingredient suppliers for technical analysis and evaluation of potential risks and safeguards; organizing and conducting an audit sharing program for providing the results of pharmaceutical supplier audits featuring technical analysis and evaluation of potential risks and safeguards
03/24/2022
RX360
Educational services, namely, providing seminars, symposia, and workshops in the field of pharmaceutical supply chain security; providing non-downloadable webinars in the field of pharmaceutical supply chain security
06/22/2021
AUDITSPLUS
Pharmaceutical product safety auditing; Medical device product safety auditing; Organizing and conducting supply chain product safety audits in the field of pharmaceuticals; Organizing and conducting supply chain product safety audits in the field of medical devices; Organizing and conducting a product safety auditing program of pharmaceutical manufacturers and suppliers, pharmaceutical ingredient manufacturers and suppliers and medical device manufacturers and suppliers for technical analysis and evaluation of potential risks and safeguards in real time and in a confidential manner; Providing a website featuring technology which provides users with the ability to access a database to organize and conduct supply chain audits in the field of pharmaceuticals and medical devices in real time and in a confidential manner
07/09/2020

See all trademarks and details in the Full Report.


Market Share of Rx-360 International Pharmaceutical Supply Chain Consortium's Largest Competitors

A competitive analysis shows these companies are in the same general field as Rx-360 International Pharmaceutical Supply Chain Consortium, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
EMBECTAParsippany, NJ100 
STRUCTURE MEDICALMooresville, NC34 
AUTOCAM MEDICAL DEVICESKentwood, MI30 
SCHARNBERG HOLDINGDes Moines, IA26 
SPECIALTY SURGICAL INSTRUMENTATIONAntioch, TN24 
MIDWEST INTERVENTIONAL SYSTEMSMaple Grove, MN19 
VITA NEEDLENeedham, MA17 
PYLANT MEDICALGrapevine, TX17 
MEDTECOrange City, IA16 




Nearby Competitors

These companies are similar in business line and location to Rx-360 International Pharmaceutical Supply Chain Consortium. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
ORTHOPLIPhiladelphia, PA100 
ALLEVIPhiladelphia, PA42 
RX-360 INTERNATIONAL PHARMACEUTICAL SUPPLY CHAIN CONSORTIUMPhiladelphia, PA20 
PREMIA SPINEPhiladelphia, PA15 
SHIELDS-DINAPhiladelphia, PA9 
BONEL MEDICAL EQUIPMENTPhiladelphia, PA4 




Future Competition: Rx-360 International Pharmaceutical Supply Chain Consortium's Fastest Growing Competitors

These companies are in the same general field as Rx-360 International Pharmaceutical Supply Chain Consortium and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Rx-360 International Pharmaceutical Supply Chain Consortium Competitors